Glomerulonephritis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
(12 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{Glomerulonephritis}} | {{Glomerulonephritis}} | ||
{{CMG}}; {{AE}}{{HK}} | |||
==Overview== | ==Overview== | ||
Glomerulonephritis may be proliferative or non-proliferative and may be associated with [[Nephrotic syndrome|nephrotic]] or [[Nephritic syndrome|nephritic]] features. The various types of glomerulonephritides should be differentiated from each other based on associations, presence of [[pitting edema]], hemeturia, [[hypertension]], [[hemoptysis]], [[oliguria]], peri-orbital edema, [[hyperlipidemia]], type of [[antibodies]], [[Light microscope|light]] and [[Electron microscopy|electron microscopic]] features. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
The following table differentiates between various types of glomerulonephritides: | |||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="3" |Glomerulonephritis | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Glomerulonephritis | ||
! rowspan="3" |Sub-entity | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Sub-entity | ||
! rowspan="3" |Causes and associations | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Causes and associations | ||
! colspan="7" rowspan="2" |History and Symtoms | ! colspan="7" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History and Symtoms | ||
! colspan="9" |Laboratory Findings | ! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings | ||
|- | |- | ||
! rowspan="2" |Hyperlipidemia and hypercholesterolemia | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Hyperlipidemia and hypercholesterolemia | ||
! rowspan="2" |Nephrotic features | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Nephrotic features | ||
! rowspan="2" |Nephritic features | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Nephritic features | ||
! rowspan="2" |ANCA | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |ANCA | ||
! rowspan="2" |Anti-glomerular basement membrane antibody (Anti-GBM antibody) | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Anti-glomerular basement membrane antibody (Anti-GBM antibody) | ||
! rowspan="2" |Immune complex formation | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Immune complex formation | ||
! rowspan="2" |Light microscope | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Light microscope | ||
! rowspan="2" |Electron microscope | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Electron microscope | ||
! rowspan="2" |Immunoflourescence pattern | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunoflourescence pattern | ||
|- | |- | ||
!History | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ||
!Pitting edema | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pitting edema | ||
!Hemeturia ( | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemeturia (pre-dominantly microscopic) | ||
!Hypertension | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hypertension | ||
!Hemoptysis | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis | ||
!Oliguria | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Oliguria | ||
!Peri-orbital edema | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Peri-orbital edema | ||
|- | |- | ||
| rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Non-proliferative | |||
!Minimal change disease | !Minimal change disease | ||
| | |||
* Idiopathic | * Idiopathic | ||
* Protein tyrosine phosphatase receptor type O (glomerular epithelial protein 1- GLEPP1) | * Protein tyrosine phosphatase receptor type O (glomerular epithelial protein 1- GLEPP1) | ||
| | |||
* Young children | * Young children | ||
* Recent infection and immunization | * Recent infection and immunization | ||
Line 42: | Line 45: | ||
* Hodgkin lymphoma | * Hodgkin lymphoma | ||
* Thrombosis (due to urinary loss of antithrombin-III) | * Thrombosis (due to urinary loss of antithrombin-III) | ||
| | |||
+ | |||
| | |||
- | |||
| | |||
- | |||
| | |||
- | |||
| | |||
+/- | |||
| | |||
- | |||
| | |||
+ | |||
| | |||
+ | |||
| | |||
- | |||
| | |||
- | |||
| | |||
- | |||
| | |||
- | |||
| | |||
* Normal | * Normal | ||
| | |||
* Fusion of podocytes | * Fusion of podocytes | ||
| | |||
- | |||
|- | |- | ||
!Focal segmental glomerulosclerosis | !Focal segmental glomerulosclerosis | ||
Line 87: | Line 103: | ||
| | | | ||
* Effacement of podocytes | * Effacement of podocytes | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
!Membranous glomerulonephritis | !Membranous glomerulonephritis | ||
Line 113: | Line 129: | ||
| | | | ||
* Sub-epithelial immune complex depositis with 'spike and dome' appearance | * Sub-epithelial immune complex depositis with 'spike and dome' appearance | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
| rowspan="7" |Proliferative | | rowspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Proliferative | ||
!IgA nephropathy | |||
| | | | ||
* Idiopathic | * Idiopathic | ||
Line 140: | Line 156: | ||
| | | | ||
* Mesangial proliferation | * Mesangial proliferation | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
! rowspan="5" |Rapidly progressive glomerulonephritis | |||
| | | | ||
* Goodpasture syndrome | * Goodpasture syndrome | ||
| | | | ||
* Young adults | * Young adults | ||
|<nowiki>+/-</nowiki> | |<nowiki>+/-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 167: | Line 178: | ||
* Hypercellular and inflamed glomeruli (Crescent formation) | * Hypercellular and inflamed glomeruli (Crescent formation) | ||
| | | | ||
* Diffuse thickening of the glomerular basement membrane with absence of subepithelial and subendothelial deposits | |||
|<nowiki>+ (Linear)</nowiki> | |<nowiki>+ (Linear)</nowiki> | ||
|- | |- | ||
Line 181: | Line 193: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 191: | Line 203: | ||
| | | | ||
* Sub-epithelial immune complex deposits | * Sub-epithelial immune complex deposits | ||
| | | + (Granular) | ||
|- | |- | ||
| | | | ||
* Granulomatosis with polyangitis (Wegner's granulomatosis) | * Granulomatosis with polyangitis (Wegner's granulomatosis) | ||
| | | | ||
* Necrotizing granulomas (Nasopharynx, lungs, kidneys) | * Necrotizing granulomas (Nasopharynx, lungs, kidneys) | ||
* [[Conjunctivitis]] | * [[Conjunctivitis]] | ||
* Ulceration of the [[cornea]] | * Ulceration of the [[cornea]] | ||
* [[Episcleritis]] | * [[Episcleritis]] | ||
* Peripheral neuropathy | * Peripheral neuropathy | ||
| | |<nowiki>+/-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 220: | Line 227: | ||
| | | | ||
* Hypercellular and inflamed glomeruli (Crescent formation) | * Hypercellular and inflamed glomeruli (Crescent formation) | ||
| | |<nowiki>- (pauci-immune)</nowiki> | ||
|<nowiki>+/-</nowiki> | |||
| | |||
|- | |- | ||
| | | | ||
* Churg Strauss syndrome | * Churg Strauss syndrome | ||
| | | | ||
* Necrotizing granulomas (Lungs and kidneys) | |||
* Necrotizing granulomas | |||
* Asthma | * Asthma | ||
* Peripheral neuropathy | * Peripheral neuropathy | ||
| | |<nowiki>+/-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 247: | Line 248: | ||
+ (C-ANCA) | + (C-ANCA) | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | | | ||
* Hypercellular and inflamed glomeruli (Crescent formation) | * Hypercellular and inflamed glomeruli (Crescent formation) | ||
| | |<nowiki>- (pauci-immune)</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
| | | | ||
* Microscopic polyngitis | * Microscopic polyngitis | ||
| | | | ||
* Necrotizing vasculitis (no granuloma) | * Necrotizing vasculitis (no granuloma) | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | |||
| | |||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
Line 274: | Line 270: | ||
+ (P-ANCA) | + (P-ANCA) | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
| | | | ||
* Hypercellular and inflamed glomeruli (Crescent formation) | * Hypercellular and inflamed glomeruli (Crescent formation) | ||
| | |<nowiki>- (pauci-immune)</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|- | |- | ||
!Membranoproliferative glomerulonephritis | |||
| | | | ||
* Idiopathic | * Idiopathic | ||
Line 290: | Line 286: | ||
* Periorbital edema | * Periorbital edema | ||
* Hypertension | * Hypertension | ||
| | |<nowiki>+/-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | |||
| | | | ||
* Thick glomerular basement membrane (Tram-track appearance) | |||
| | | | ||
* Mesangial proliferation and leukocyte infiltration | |||
| | |<nowiki>+ (Granular)</nowiki> | ||
|} | |} | ||
Line 314: | Line 312: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Organ disorders]] | [[Category:Organ disorders]] | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] |
Latest revision as of 21:53, 29 July 2020
Glomerulonephritis Main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Glomerulonephritis may be proliferative or non-proliferative and may be associated with nephrotic or nephritic features. The various types of glomerulonephritides should be differentiated from each other based on associations, presence of pitting edema, hemeturia, hypertension, hemoptysis, oliguria, peri-orbital edema, hyperlipidemia, type of antibodies, light and electron microscopic features.
Differential Diagnosis
The following table differentiates between various types of glomerulonephritides:
Glomerulonephritis | Sub-entity | Causes and associations | History and Symtoms | Laboratory Findings | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hyperlipidemia and hypercholesterolemia | Nephrotic features | Nephritic features | ANCA | Anti-glomerular basement membrane antibody (Anti-GBM antibody) | Immune complex formation | Light microscope | Electron microscope | Immunoflourescence pattern | ||||||||||
History | Pitting edema | Hemeturia (pre-dominantly microscopic) | Hypertension | Hemoptysis | Oliguria | Peri-orbital edema | ||||||||||||
Non-proliferative | Minimal change disease |
|
|
+ |
- |
- |
- |
+/- |
- |
+ |
+ |
- |
- |
- |
- |
|
|
- |
Focal segmental glomerulosclerosis |
|
|
+ | - | - | - | +/- | - | + | + | - | - | - | - |
|
|
- | |
Membranous glomerulonephritis |
|
+ | - | - | - | +/- | - | + | + | - | - | - | + |
|
|
- | ||
Proliferative | IgA nephropathy |
|
|
+/- | + | + | - | + | +/- | - | - | + | - | - | + |
|
|
- |
Rapidly progressive glomerulonephritis |
|
|
+/- | + | + | + | + | + | - | - | + | - | + | + |
|
|
+ (Linear) | |
|
|
+/- | + | + | + | + | + | - | - | + | - | - | + |
|
|
+ (Granular) | ||
|
|
+/- | + | + | + | + | + | - | - | + | + (C-ANCA) | - | - |
|
- (pauci-immune) | +/- | ||
|
|
+/- | + | + | + | + | + | - | - | + |
+ (C-ANCA) |
- | - |
|
- (pauci-immune) | - | ||
|
|
+/- | + | + | + | + | + | - | - | + |
+ (P-ANCA) |
- | - |
|
- (pauci-immune) | - | ||
Membranoproliferative glomerulonephritis |
|
|
+/- | + | + | + | + | + | - | + | - | - | - | + |
|
|
+ (Granular) |